Holoprosencephaly
Introduction to Holoprosencephaly
Holoforeencephaly is a complex disease involving craniofacial malformations or lesions caused by developmental defects in the forebrain. It causes multiple deformities of the nervous system and face, which occur in about 1 in 8,000 individuals, and has a poor prognosis for central nervous system function. The cause of the disease is unclear, but some studies suggest a genetic link. Normally, the primitive forebrain divides and breaks into the telencephalon, the forebrain, and divides into the ventricle system during the fourth to eighth weeks of fetal life. However, when this process is disrupted, a large part of the forebrain is left undivided, leading to craniofacial deformities.
The Pathological Features of Holoprosencephaly
The basic pathological features were unilateral ventricle with incomplete lateral ventricle, without falx cerebrum, corpus callosum, septum pellucida, and the fissure between hemispheres. The brain weight was less than 100g, including only a residual primitive midline sulcus, which was large and simple in structure. The basal ganglia and the colliculus nucleus were not differentiated, and there was a single anterior cerebral artery. Therefore, according to different degrees of differentiation, it can be divided into three main subtypes: anencephalic type, hemispherical type, and whole lobe type.
Clinical Characteristics of Holoprosencephaly
Anloboencephaly is rare and often results in miscarriage, stillbirth, or death within 1 year of age. There have been several cases of anloboencephaly in China, all of which presented with low intelligence and cerebral palsy. Hemispherical type patients generally have a small head, mental retardation, cerebral palsy. Patients with lobular and septal dysplasia may live to adulthood and often present with various neuropsychiatric symptoms, such as motor retardation and mental retardation, which is common in epilepsy. In addition, there may also be visual impairment, optic disc dysplasia, coarse nystagmus, and hypothalamic-pituitary dysfunction resulting in diabetes avalanche, dwarfism, and other symptoms. However, each type has different degrees of facial midline structure malformations, such as one-eye, cleft lip, corpus callosum dysplasia.
Fig.1 Signaling pathways involved in the pathogenesis of holoprosencephaly. (Geng, 2009)
Research on Holoprosencephaly
Over the past few years, different studies have identified many mutations in genes, such as GLI2, ZIC2, and SIX3, responsible for severe holoprosencephaly. At the same time, whole-exome sequencing technology is emerging as a powerful new tool for screening the causes of holoprosencephaly. For example, using whole-exome sequencing, the researchers found that children with cortical dysplasia from different populations shared a missense mutation in the SHH gene (600725.0019). Furthermore, identifying the pathogenic cause of different kinds of holoprosencephaly can provide a basis for genetic counseling of various families or populations.
Besides, many companies and organizations have generated a wide spectrum of holoprosencephaly-related products or neuroscience research tools, such as Neural Proteins & Peptides, Neural Antibodies, Neural Cell Lines, as well as Animal Models to reveal the molecular basis for holoprosencephaly cause, diagnosis, and treatment. In addition, a series of signaling pathways, like Nodal, Shh, or Bmp signaling pathways have been widely studied that have shown a promising role in analyzing the pathogenesis of holoprosencephaly.
Creative Biolabs is a leader in the field of developmental disorders studies and has focused on providing products and solutions to neuroscience studies for years. We have experienced experts and advanced platforms that can provide excellent services. If you are interested in our services, please contact us for more details.
Reference
- Geng, X.; et al. Pathogenesis of holoprosencephaly. The Journal of clinical investigation. 2009, 119(6): 1403-1413.
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)